Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for GEODON
- Reducing the Abuse Liability of Prescription Opioids
- Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia
- Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder
- A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
- Gene-by-Stress Interactions in Intervention Studies Significance
- The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment
- Outcomes of Antipsychotic Medication Used in the Emergency Department
- A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia
- Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania
- 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
- Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome
- Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions
- Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions
- Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad)
- The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
- Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)
- Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder
- Ziprasidone in Early Onset Schizophrenia Spectrum Disorders
- Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone
- Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
- Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules
- A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
- Ziprasidone in the Psychosis Prodrome
- Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs
- Ziprasidone in Pediatric Bipolar Disorder
- Treatment of Schizophrenic Patients With Ziprasidone
- A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
- Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone
- Glucose and Lipid Metabolism on Antipsychotic Medication
- Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State
- Geodon in Weight Loss Study for Bipolar Disorders
- Open-label Ziprasidone Study for Psychosis Treatment in Adolescents
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia Symptoms
- Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder
- Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder
- Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression
- Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
- Ziprasidone And Olanzapine's Outcomes In Mania
- Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
- A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.
- Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia
- Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia
- Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression
- Geodon for the Treatment of Refractory Social Anxiety Disorder
- Ziprasidone in Children With Autism: A Pilot Study
- Geodon (Ziprasidone) for Posttraumatic Stress Disorder
- A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression
- Switching Medication to Treat Schizophrenia
Clinical trials list
click for details